Literature DB >> 30519875

Bilateral trigeminal root entry zone enhancement in MOG-IgG-associated brainstem encephalitis.

Yaoyao Shen1, Zhijuan Cheng2, Chenguang Zhou3.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 30519875     DOI: 10.1007/s10072-018-3668-8

Source DB:  PubMed          Journal:  Neurol Sci        ISSN: 1590-1874            Impact factor:   3.307


× No keyword cloud information.
  5 in total

1.  Seizures and Encephalitis in Myelin Oligodendrocyte Glycoprotein IgG Disease vs Aquaporin 4 IgG Disease.

Authors:  Shahd H M Hamid; Dan Whittam; Mariyam Saviour; Amal Alorainy; Kerry Mutch; Samantha Linaker; Tom Solomon; Maneesh Bhojak; Mark Woodhall; Patrick Waters; Richard Appleton; Martin Duddy; Anu Jacob
Journal:  JAMA Neurol       Date:  2018-01-01       Impact factor: 18.302

2.  Distinction between MOG antibody-positive and AQP4 antibody-positive NMO spectrum disorders.

Authors:  Douglas Kazutoshi Sato; Dagoberto Callegaro; Marco Aurelio Lana-Peixoto; Patrick J Waters; Frederico M de Haidar Jorge; Toshiyuki Takahashi; Ichiro Nakashima; Samira Luisa Apostolos-Pereira; Natalia Talim; Renata Faria Simm; Angelina Maria Martins Lino; Tatsuro Misu; Maria Isabel Leite; Masashi Aoki; Kazuo Fujihara
Journal:  Neurology       Date:  2014-01-10       Impact factor: 9.910

3.  Trigeminal root entry zone involvement in neuromyelitis optica and multiple sclerosis.

Authors:  Atsuhiko Sugiyama; Masahiro Mori; Hiroki Masuda; Tomohiko Uchida; Mayumi Muto; Akiyuki Uzawa; Shoichi Ito; Satoshi Kuwabara
Journal:  J Neurol Sci       Date:  2015-06-03       Impact factor: 3.181

4.  MOG-IgG in NMO and related disorders: a multicenter study of 50 patients. Part 3: Brainstem involvement - frequency, presentation and outcome.

Authors:  Sven Jarius; Ingo Kleiter; Klemens Ruprecht; Nasrin Asgari; Kalliopi Pitarokoili; Nadja Borisow; Martin W Hümmert; Corinna Trebst; Florence Pache; Alexander Winkelmann; Lena-Alexandra Beume; Marius Ringelstein; Oliver Stich; Orhan Aktas; Mirjam Korporal-Kuhnke; Alexander Schwarz; Carsten Lukas; Jürgen Haas; Kai Fechner; Mathias Buttmann; Judith Bellmann-Strobl; Hanna Zimmermann; Alexander U Brandt; Diego Franciotta; Kathrin Schanda; Friedemann Paul; Markus Reindl; Brigitte Wildemann
Journal:  J Neuroinflammation       Date:  2016-11-01       Impact factor: 8.322

Review 5.  MOG encephalomyelitis: international recommendations on diagnosis and antibody testing.

Authors:  S Jarius; F Paul; O Aktas; N Asgari; R C Dale; J de Seze; D Franciotta; K Fujihara; A Jacob; H J Kim; I Kleiter; T Kümpfel; M Levy; J Palace; K Ruprecht; A Saiz; C Trebst; B G Weinshenker; B Wildemann
Journal:  J Neuroinflammation       Date:  2018-05-03       Impact factor: 8.322

  5 in total
  2 in total

1.  Clinical characteristics of MOG antibody disease: two case reports.

Authors:  Yujia Guan; Zunwei Zhang; Mingming Li; Miao Shi; Hui Deng
Journal:  Neurol Sci       Date:  2021-02-10       Impact factor: 3.307

2.  Comparative study of AQP4-NMOSD, MOGAD and seronegative NMOSD: a single-center Belgian cohort.

Authors:  Solène Dauby; Dominique Dive; Laurence Lutteri; Cécile Andris; Isabelle Hansen; Pierre Maquet; Emilie Lommers
Journal:  Acta Neurol Belg       Date:  2021-06-07       Impact factor: 2.396

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.